Accessed November 13, 2024 [21] Shrivastava S, Sharma A, Saxena N, Bhamra R, Kumar S
Tirzepatide represents a dual agonist, activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may explain its particularly robust weight loss effects
They can also be prescribed off-label for weight loss
Ozempic, sa svim navedenim efektima moda i ne bi bio toliko popularan i moda se o njemu ne bi toliko ni govorilo da nisu poele da ga koriste i promoviu poznate linosti koje nemaju zdravstvenih problema, ve jednostavno iz elje da smraju
Diarrhea is also a common GLP-1 side effect, and it can cause rapid fluid loss
It also helps minimize muscle loss that can happen when youre eating on a GLP-1 medication